 | ||
 | ||
 | ||
Email
Glossary |
|
any clinical trials for rimonabant May 14, 2004 I've read some interesting news about rimonabant and it's positive effect on reducing lipids, triglycerides, etc. Is anyone doing a clinical trial to see if it would help HIV+ patients with lipodystrophy? Thank-you. |
|
 |
|||
|
|||
 |
|
Response from Ms. Fields-Gardner
 I was unable to find information on a trial with rimonabant and cardiovascular disease risk markers or lipodystrophy. There is a trial under recruitment to assess the ability of the drug to reduce voluntary alcohol consumption presumably by blocking cannabinoid receptors. By doing this, the drug is suggested to block cravings, such as hunger, smoking, and alcohol consumption. Things may change, but at this time I am not sure that this drug has a role to play in lipodystrophy. |
|
| |
Q&A TERMS OF USE
This forum is designed for educational purposes only, and experts are not rendering legal or medical advice or professional services. Experts appearing on this page are independent and are solely responsible for editing and fact-checking their material. Neither TheBody.com nor any sponsor is the publisher or speaker of posted visitors' questions or the experts' material.
Review our complete terms of use and copyright notice.
